Tiprogrel

N/A

Report date: 2024/09/06 15:49:54

Base Information

Drug NameTiprogrel
Drug Alias NameTaiPuGeLeiTY601ATY-601A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsIschemic StrokeAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Remedy Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Remedy Research Institute
Inactive CompaniesN/A
Active IndicationsIschemic StrokeAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A